An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells
2007

Metabolic Differences in Estrogen Receptor Positive Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Mandal Soma, Davie James R

Primary Institution: Manitoba Institute of Cell Biology, University of Manitoba

Hypothesis

This study examines metabolic differences between estrogen receptor positive breast cancer cells during estrogen deprivation.

Conclusion

The study shows that ZR75-1 cells use genes and pathways differently from MCF-7 cells, which may contribute to their aggressiveness.

Supporting Evidence

  • MCF-7 cells showed higher gene utilization than ZR75-1 in all GO terms.
  • ZR75-1 cells had a down-regulated immune function and up-regulated glucose metabolism.
  • Both cell lines exhibited similarities in gene expression patterns despite differences in specific pathways.

Takeaway

The study looks at how two types of breast cancer cells behave differently when they don't have estrogen, which might help us understand why some cancers are more aggressive.

Methodology

The study used public gene expression data from breast cancer cell lines and normal breast tissue to analyze metabolic differences.

Limitations

The study is based on in silico analysis and may not fully represent in vivo conditions.

Statistical Information

P-Value

p ≤ 0.05

Statistical Significance

p ≤ 0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-181

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication